🇺🇸 quadrivalent human papillomavirus vaccine in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Abortion Spontaneous — 1 report (100%)
Frequently asked questions
Is quadrivalent human papillomavirus vaccine approved in United States?
quadrivalent human papillomavirus vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for quadrivalent human papillomavirus vaccine in United States?
University of Pittsburgh is the originator. The local marketing authorisation holder may differ — check the official source linked above.